{"id":"https://openalex.org/W4384501635","doi":"https://doi.org/10.1136/bmjresp-2023-001627","title":"Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial","display_name":"Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial","publication_year":2023,"publication_date":"2023-07-01","ids":{"openalex":"https://openalex.org/W4384501635","doi":"https://doi.org/10.1136/bmjresp-2023-001627","pmid":"https://pubmed.ncbi.nlm.nih.gov/37460276","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10357723"},"language":"en","primary_location":{"id":"doi:10.1136/bmjresp-2023-001627","doi":"https://doi.org/10.1136/bmjresp-2023-001627","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjresp-2023-001627","pdf_url":"https://bmjopenrespres.bmj.com/content/bmjresp/10/1/e001627.full.pdf","source":{"id":"https://openalex.org/S2736820664","display_name":"BMJ Open Respiratory Research","issn_l":"2052-4439","issn":["2052-4439"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open Respiratory Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmjopenrespres.bmj.com/content/bmjresp/10/1/e001627.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019397106","display_name":"John A. Belperio","orcid":"https://orcid.org/0000-0003-2379-5486","observed_orcids":["https://orcid.org/0000-0003-2379-5486"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Belperio","raw_affiliation_strings":["Ronald Reagan UCLA Medical Center, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ronald Reagan UCLA Medical Center, Los Angeles, California, USA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I2801272649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112263320","display_name":"Tuan S. Nguyen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tuan Nguyen","raw_affiliation_strings":["Theravance Biopharma Inc, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma Inc, South San Francisco, California, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059739934","display_name":"David A. Lombardi","orcid":"https://orcid.org/0000-0001-6151-2024","observed_orcids":["https://orcid.org/0000-0001-6151-2024"]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A Lombardi","raw_affiliation_strings":["Theravance Biopharma Inc, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma Inc, South San Francisco, California, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017314473","display_name":"Maxim Bogus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maxim Bogus","raw_affiliation_strings":["Arensia Exploratory Medicine SRL, Chi\u0219in\u0103u, Moldova (the Republic of)","Timofei Mosneaga Republican Hospital, Chi\u0219in\u0103u, Moldova (the Republic of)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arensia Exploratory Medicine SRL, Chi\u0219in\u0103u, Moldova (the Republic of)","institution_ids":[]},{"raw_affiliation_string":"Timofei Mosneaga Republican Hospital, Chi\u0219in\u0103u, Moldova (the Republic of)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110644421","display_name":"Valentyn Moskalenko","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valentyn Moskalenko","raw_affiliation_strings":["Arensia Exploratory Medicine, LLC, Kyiv City Clinical Hospital #12, Oleksandrivska Kyiv City Clinical Hospital, Kyiv, Ukraine","Brovary Multidisciplinary Clinical Hospital, Brovary, Ukraine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arensia Exploratory Medicine, LLC, Kyiv City Clinical Hospital #12, Oleksandrivska Kyiv City Clinical Hospital, Kyiv, Ukraine","institution_ids":[]},{"raw_affiliation_string":"Brovary Multidisciplinary Clinical Hospital, Brovary, Ukraine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068917661","display_name":"Dave Singh","orcid":"https://orcid.org/0000-0001-8918-7075","observed_orcids":["https://orcid.org/0000-0001-8918-7075"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210092852","display_name":"Manchester University NHS Foundation Trust","ror":"https://ror.org/00he80998","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852"]},{"id":"https://openalex.org/I4210151016","display_name":"Medicines Evaluation Unit","ror":"https://ror.org/05e497m36","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210151016"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dave Singh","raw_affiliation_strings":["Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210092852","https://openalex.org/I4210151016"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034939345","display_name":"Brett Haumann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brett Haumann","raw_affiliation_strings":["Theravance Biopharma UK Limited, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma UK Limited, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027600676","display_name":"David L. Bourdet","orcid":"https://orcid.org/0000-0001-6220-1922","observed_orcids":["https://orcid.org/0000-0001-6220-1922"]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David L Bourdet","raw_affiliation_strings":["Theravance Biopharma Inc, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma Inc, South San Francisco, California, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112137819","display_name":"Elad Kaufman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elad Kaufman","raw_affiliation_strings":["Theravance Biopharma Inc, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma Inc, South San Francisco, California, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112751556","display_name":"Nathan D. Pfeifer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathan D Pfeifer","raw_affiliation_strings":["Theravance Biopharma Inc, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma Inc, South San Francisco, California, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008278176","display_name":"Corbin G. Thompson","orcid":"https://orcid.org/0000-0003-2559-1030","observed_orcids":["https://orcid.org/0000-0003-2559-1030"]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corbin G Thompson","raw_affiliation_strings":["Theravance Biopharma Inc, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma Inc, South San Francisco, California, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109499570","display_name":"Jacky Woo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacky Woo","raw_affiliation_strings":["Theravance Biopharma Inc, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma Inc, South San Francisco, California, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109142964","display_name":"Edmund J. Moran","orcid":"https://orcid.org/0000-0001-5066-4866","observed_orcids":["https://orcid.org/0000-0001-5066-4866"]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Edmund J Moran","raw_affiliation_strings":["Theravance Biopharma Inc, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma Inc, South San Francisco, California, USA","institution_ids":["https://openalex.org/I4210133216"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039783745","display_name":"Rajeev Saggar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133216","display_name":"Theravance Biopharma (United States)","ror":"https://ror.org/03a6z4w08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133216"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajeev Saggar","raw_affiliation_strings":["Theravance Biopharma Inc, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theravance Biopharma Inc, South San Francisco, California, USA","institution_ids":["https://openalex.org/I4210133216"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5109142964"],"corresponding_institution_ids":["https://openalex.org/I4210133216"],"apc_list":{"value":1700,"currency":"GBP","value_usd":2085},"apc_paid":{"value":1700,"currency":"GBP","value_usd":2085},"fwci":1.9259,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.84316757,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"10","issue":"1","first_page":"e001627","last_page":"e001627"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10322","display_name":"Respiratory Support and Mechanisms","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.7279999852180481},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9150000214576721},{"id":"https://openalex.org/keywords/respiratory-failure","display_name":"respiratory failure","score":0.7919999957084656},{"id":"https://openalex.org/keywords/oxygen-saturation","display_name":"oxygen saturation","score":0.6269999742507935},{"id":"https://openalex.org/keywords/28-day-mortality","display_name":"28-day mortality","score":0.949999988079071},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8539999723434448},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.6179999709129333},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8335634469985962},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.7164885401725769},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6411948204040527},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.5996477007865906},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.562156081199646},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.4896460175514221},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.47596901655197144},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.4531075358390808},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42399224638938904},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.423429399728775},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3457757234573364},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24829527735710144},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2292904257774353},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000075242","descriptor_name":"Janus Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010100","descriptor_name":"Oxygen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012131","descriptor_name":"Respiratory Insufficiency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1136/bmjresp-2023-001627","doi":"https://doi.org/10.1136/bmjresp-2023-001627","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjresp-2023-001627","pdf_url":"https://bmjopenrespres.bmj.com/content/bmjresp/10/1/e001627.full.pdf","source":{"id":"https://openalex.org/S2736820664","display_name":"BMJ Open Respiratory Research","issn_l":"2052-4439","issn":["2052-4439"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open Respiratory Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10357723","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10357723","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10357723/pdf/bmjresp-2023-001627.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open Respir Res","raw_type":"Text"},{"id":"pmid:37460276","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37460276","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ open respiratory research","raw_type":"Randomized Controlled Trial"},{"id":"pmh:oai:ibn.idsi.md:185965","doi":null,"is_oa":true,"landing_page_url":"https://ibn.idsi.md/vizualizare_articol/185965","pdf_url":"https://ibn.idsi.md/sites/default/files/imag_file/Efficacy-and-safety-of-an-inhaled-panJanus-kinase-inhibitor-nezulcitinib-in-hospitalised-patients-with-COVID19-results-from-a-phase-2-clinical-trialBMJ-Open-Respiratory-Research.pdf","source":null,"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMJ Open Respiratory Research 0-0","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:905da654e8a64ea59f91db7bc7d56b1d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/905da654e8a64ea59f91db7bc7d56b1d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMJ Open Respiratory Research, Vol 10, Iss 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/bmjresp-2023-001627","doi":"https://doi.org/10.1136/bmjresp-2023-001627","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjresp-2023-001627","pdf_url":"https://bmjopenrespres.bmj.com/content/bmjresp/10/1/e001627.full.pdf","source":{"id":"https://openalex.org/S2736820664","display_name":"BMJ Open Respiratory Research","issn_l":"2052-4439","issn":["2052-4439"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open Respiratory Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G2458241236","display_name":"Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)","funder_award_id":"P01HL108793","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320314713","display_name":"Theravance Biopharma US","ror":"https://ror.org/03a6z4w08"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4384501635.pdf","grobid_xml":"https://content.openalex.org/works/W4384501635.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W2167980330","https://openalex.org/W2529532071","https://openalex.org/W2592397452","https://openalex.org/W3001118548","https://openalex.org/W3002108456","https://openalex.org/W3024128175","https://openalex.org/W3027630905","https://openalex.org/W3028583791","https://openalex.org/W3041319886","https://openalex.org/W3042270788","https://openalex.org/W3081275185","https://openalex.org/W3110844195","https://openalex.org/W3113196149","https://openalex.org/W3156297617","https://openalex.org/W3167671574","https://openalex.org/W3168338972","https://openalex.org/W3177306882","https://openalex.org/W3188676168","https://openalex.org/W3197608731","https://openalex.org/W4205799127","https://openalex.org/W4211144854","https://openalex.org/W4288459457"],"related_works":["https://openalex.org/W4312422541","https://openalex.org/W4225298557","https://openalex.org/W3186611466","https://openalex.org/W3177306882","https://openalex.org/W4210350234","https://openalex.org/W4220668224","https://openalex.org/W3197608731","https://openalex.org/W3030158388","https://openalex.org/W3049911747","https://openalex.org/W4304957552"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1],"inhaled":[2],"lung-selective":[3],"pan-Janus":[4],"kinase":[5],"inhibitor":[6],"nezulcitinib":[7,66,146,204,224],"had":[8,210],"favourable":[9,171,212],"safety":[10,99,172,213],"and":[11,100,115,128,180,197,209],"potential":[12],"efficacy":[13,162,182],"signals":[14],"in":[15,23,149,228],"part":[16,31],"1":[17],"of":[18,107,233],"a":[19,37,120,170,211],"phase":[20,40],"2":[21,35,41],"trial":[22],"patients":[24,45,132,234],"with":[25,49,76,169,223,235],"severe":[26],"COVID-19,":[27],"supporting":[28],"progression":[29],"to":[30,64,73,219],"2.":[32],"METHODS:":[33],"Part":[34],"was":[36,119,140,165,205],"randomised,":[38],"double-blind":[39],"study":[42],"(NCT04402866).":[43],"Hospitalised":[44],"aged":[46],"18-80":[47],"years":[48],"confirmed":[50],"symptomatic":[51],"COVID-19":[52],"requiring":[53],"supplemental":[54],"oxygen":[55,104,109],"(excluding":[56],"baseline":[57,103,191],"invasive":[58],"mechanical":[59],"ventilation)":[60],"were":[61,133,201],"randomised":[62],"1:1":[63],"nebulised":[65],"3":[67],"mg":[68],"or":[69,160],"placebo":[70,148],"for":[71],"up":[72],"7":[74],"days":[75,88],"background":[77],"standard-of-care":[78],"therapy":[79],"(including":[80],"corticosteroids).":[81],"Efficacy":[82],"endpoints":[83,97],"included":[84,98],"respiratory":[85],"failure-free":[86],"(RFF)":[87],"through":[89,186],"day":[90,113,187,195],"28":[91],"as":[92],"the":[93,150,176],"primary":[94,151],"endpoint.":[95,123],"Secondary":[96],"change":[101,189],"from":[102,190],"saturation":[105],"(SaO2)/fraction":[106],"inspired":[108],"(FiO2)":[110],"ratio":[111,193],"on":[112,194],"7,":[114,196],"28-day":[116,198],"mortality":[117,199],"rate":[118],"prespecified":[121,177],"exploratory":[122,181],"RESULTS:":[124],"Between":[125],"June":[126],"2020":[127],"April":[129],"2021,":[130],"205":[131],"treated":[134],"(nezulcitinib,":[135],"103;":[136],"placebo,":[137],"102).":[138],"There":[139],"no":[141],"statistically":[142],"significant":[143],"difference":[144],"between":[145],"versus":[147],"endpoint":[152],"(RFF":[153],"days;":[154],"median,":[155],"21.0":[156],"vs":[157],"21.0;":[158],"p=0.6137)":[159],"secondary":[161,179],"endpoints.":[163],"Nezulcitinib":[164],"generally":[166,206],"well":[167,207],"tolerated":[168,208],"profile.":[173,214],"CONCLUSIONS:":[174],"Although":[175],"primary,":[178],"endpoints,":[183],"including":[184],"RFF":[185],"28,":[188],"SaO2/FiO2":[192],"rate,":[200],"not":[202],"met,":[203],"Further":[215],"studies":[216],"are":[217],"required":[218],"determine":[220],"if":[221],"treatment":[222],"confers":[225],"clinical":[226],"benefit":[227],"specific":[229],"inflammatory":[230],"biomarker-defined":[231],"populations":[232],"COVID-19.":[236]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-07-18T00:00:00"}